GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Change in Cash (2020 - 2026)

GH Research (GHRS) posted quarterly Change in Cash of -$3.6 million for Q4 2025, down 132.87% year-over-year from $10.8 million in Q4 2024, and up 10.24% quarter-over-quarter from -$4.0 million in Q3 2025.

Analysis

GH Research (GHRS) Change in Cash (2020 - 2026) Analysis & Trends

GH Research's Change in Cash history runs 6 years deep, the most recent figure standing at -$3.6 million for Q4 2025.

  • In Q4 2025, Change in Cash fell 132.87% year-over-year to -$3.6 million; the TTM figure through Dec 2025 stood at $142.3 million (up 531.03% YoY), while the FY2025 annual figure was $142.3 million, up 531.03% from the prior year.
  • Change in Cash for Q4 2025 stood at -$3.6 million, up from -$4.0 million in the prior quarter.
  • The five-year high for Change in Cash was $288.0 million in Q2 2021, with the low at -$91.5 million in Q4 2022.
  • The 5-year median for Change in Cash is -$4.0 million (2021), against an average of $11.9 million.
  • The sharpest annual moves came in 2021 and 2025: Change in Cash slumped 15309.09% in 2021, then soared 16496.25% in 2025.
  • GH Research's Change in Cash stood at -$3.9 million in 2021, then sank by 2217.78% to -$91.5 million in 2022, then soared by 91.09% to -$8.2 million in 2023, then surged by 232.83% to $10.8 million in 2024, then sank by 132.87% to -$3.6 million in 2025.
  • Business Quant data shows GHRS's Change in Cash at -$3.6 million in Q4 2025, -$4.0 million in Q3 2025, and $5.7 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 GH Research 1.72 Bn 1.36 Bn - 103.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103.19 Mn
Mar 31, 2026 -2.03 Mn
Dec 31, 2025 -3.56 Mn
Sep 30, 2025 -3.96 Mn
Jun 30, 2025 5.67 Mn
Mar 31, 2025 144.12 Mn
Dec 31, 2024 10.83 Mn
Sep 30, 2024 2.92 Mn
Jun 30, 2024 9.68 Mn
Mar 31, 2024 -879,000.00
Dec 31, 2023 -8.15 Mn
Sep 30, 2023 -10.40 Mn
Jun 30, 2023 -8.11 Mn
Mar 31, 2023 -60.98 Mn
Dec 31, 2022 -91.51 Mn
Sep 30, 2022 -8.06 Mn
Jun 30, 2022 -5.31 Mn
Mar 31, 2022 -6.01 Mn
Dec 31, 2021 -3.95 Mn
Sep 30, 2021 -11.87 Mn